The EU review has now concluded that Esmya may have contributed to the onset of some of the 8 cases of serious liver injury.
The following vacancies have arisen for BSG regional representatives
We formally took over the responsibilities for the IBD Registry from the BSG at the BSG Annual meeting in June 2018
Learn how Brian McKaig and his colleagues in Wolverhampton have come up with a solution to managing the increasing number of referrals from primary care
Clinical guideline [CG131]
UK consensus on non-medical staffing required to deliver safe, quality-assured care for adult patients undergoing gastrointestinal endoscopy
Dunkley I, et al. Frontline Gastroenterology 2018;0:1–11. doi:10.1136/flgastro-2017-100950
The Royal College of Pathologists
Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.